Authors:
Djurovic, S
Os, I
Hofstad, AE
Abdelnoor, M
Westheim, A
Berg, K
Citation: S. Djurovic et al., Increased plasma concentrations of TGF-beta(1) after hormone replacement therapy (vol 247, pg 279, 2000), J INTERN M, 249(3), 2001, pp. 271-271
Authors:
Os, I
Hofstad, AE
Brekke, M
Abdelnoor, M
Nesheim, BI
Jacobsen, AF
Birkeland, K
Larsen, A
Midtbo, K
Westheim, A
Citation: I. Os et al., The EWA (Estrogen in Women with Atherosclerosis) Study: a randomized studyof the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins, J INTERN M, 247(4), 2000, pp. 433-441
Authors:
Svilaas, A
Thoresen, M
Kristoffersen, JE
Hjartaaker, J
Westheim, A
Citation: A. Svilaas et al., How well are patients with atherosclerotic disease treated? Secondary prevention in primary care, SC J PRIM H, 18(4), 2000, pp. 232-236
Authors:
Olsen, H
Klemetsrud, T
Stokke, HP
Tretli, S
Westheim, A
Citation: H. Olsen et al., Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway, BLOOD PRESS, 8(2), 1999, pp. 94-101
Authors:
Hofstad, AE
Os, I
Abdelnoor, M
Platou, ES
Westheim, A
Citation: Ae. Hofstad et al., Evidence of excess hereditary predisposition in women with angiographically documented coronary artery disease, CARDIOLOGY, 90(4), 1998, pp. 249-252